Floatz logo

Allocetra-Ots

Cholecystitis, Acute

Enlivex Therapeutics Ltd.Phase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Cholecystitis, Acute cohort.

Asset / SponsorPhaseRating
Indocyanine Green
Ohio State University
Phase 1CC
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
N/AD
Zofran
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
N/AD
(±)-TRAMADOL
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
N/AD

Same molecule, other indications

Allocetra-Ots is also rated in:

pneumoniaDormant
CCC
Indicative ·
55 / 100
View asset →
infectious disease with sepsisDormant
CCC
Indicative ·
55 / 100
View asset →
urinary tract infectionDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →